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Proton irradiation orchestrates
macrophage reprogramming through
NFκB signaling
Géraldine Genard1, Anne-Catherine Wera1, Camille Huart1, Benjamin Le Calve1, Sébastien Penninckx 2,
Antoine Fattaccioli1, Tijani Tabarrant2, Catherine Demazy1, Noëlle Ninane1, Anne-Catherine Heuskin2,
Stéphane Lucas2 and Carine Michiels1
Abstract
Tumor-associated macrophages (TAMs) represent potential targets for anticancer treatments as these cells play critical
roles in tumor progression and frequently antagonize the response to treatments. TAMs are usually associated to an
M2-like phenotype, characterized by anti-inﬂammatory and protumoral properties. This phenotype contrasts with the
M1-like macrophages, which exhibits proinﬂammatory, phagocytic, and antitumoral functions. As macrophages hold a
high plasticity, strategies to orchestrate the reprogramming of M2-like TAMs towards a M1 antitumor phenotype offer
potential therapeutic beneﬁts. One of the most used anticancer treatments is the conventional X-ray radiotherapy (RT),
but this therapy failed to reprogram TAMs towards an M1 phenotype. While protontherapy is more and more used in
clinic to circumvent the side effects of conventional RT, the effects of proton irradiation on macrophages have not
been investigated yet. Here we showed that M1 macrophages (THP-1 cell line) were more resistant to proton
irradiation than unpolarized (M0) and M2 macrophages, which correlated with differential DNA damage detection.
Moreover, proton irradiation-induced macrophage reprogramming from M2 to a mixed M1/M2 phenotype. This
reprogramming required the nuclear translocation of NFκB p65 subunit as the inhibition of IκBα phosphorylation
completely reverted the macrophage re-education. Altogether, the results suggest that proton irradiation promotes
NFκB-mediated macrophage polarization towards M1 and opens new perspectives for macrophage targeting with
charged particle therapy.
Introduction
The immune system takes part in both cancer elim-
ination and tumor development, especially through its
activation and then its adaption to cancer cells1. This
process is called the cancer immunoediting and it per-
fectly illustrates the ambivalent function of the immune
system in cancer. In addition, the effectiveness of treat-
ments such as X-ray or γ-ray radiotherapy (RT) is partially
conditioned by the presence of immune cells into the
tumor. For example, ablative radiation (20 Gy) on local
tumor signiﬁcantly reduced the tumor volume in wild-
type (WT) but not in nude (T-cell-deﬁcient) mice bearing
a melanoma (B16 melanoma cells)2. In line with this
observation, local RT produces an abscopal response,
which is an antitumor effect on distant unirradiated
tumors (metastases), by triggering systemic immune
responses3. Another example is the systemic immune
activation in mice previously treated by local RT and
immune checkpoint inhibitors that prevented the tumor
growth in mice rechallenged with the same tumor4.
However, the number of inﬁltrating tumor-associated
macrophages (TAMs) is known to limit radiotherapy
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efﬁciency and is directly correlated to a poor prognosis5.
Inside the tumor, TAMs represent up to 50% of the host
inﬁltrating cells6, 7, meaning that these cells are highly
recruited into the tumor site and play critical roles in
tumor development. It has been shown that RT promotes
the recruitment of macrophages into the tumor, favoring
tumor relapse after treatment8. Indeed, TAM depletion or
inhibition of monocyte recruitment into the tumor site
combined to RT induce tumor regression in mouse can-
cer models and increase the survival of cancer patients9,
10. Another attractive and effective strategy is the re-
education of TAMs towards an antitumoral phenotype.
Macrophages display a remarkable plasticity allowing
them to fulﬁll a multiple range of functions. These
multitask skills rely on two opposite phenotypes, M1
versus M2. These two subpopulations are classiﬁed as
two extremes of a linear scale between which exists a
multitude of intermediate states11. Proinﬂammatory M1
macrophages, also called classically activated macro-
phages, exhibit enhanced pathogen phagocytosis, pro-
mote inﬂammation, and activate immune system. On
the opposite, anti-inﬂammatory M2 macrophages,
referred to as alternatively activated macrophages,
contribute to tissue repair, matrix remodeling, and
angiogenesis, and also repress the immune system. It is
well accepted that M1 macrophages exert antitumor
functions while M2 macrophages show protumoral
activity and, unfortunately, are usually the most repre-
sentative TAM population into the tumor12. M2-like
TAMs display their harmful actions by promoting
genetic instability, stem cell nurturing, angiogenesis,
metastasis spreading, and local immunosuppression8.
The polarization of macrophages towards an M1 or an
M2 phenotype is driven by the activity of diverse tran-
scription factors and miRNAs. Among transcription
factors, NFκB plays a central role to inﬂuence the
inﬂammatory macrophage status. While the active het-
erodimer NFκB (p50–p65) promotes the transcription
of proinﬂammatory genes, such as TNFα, IL-6, and
IL1β, the inactive homodimer NFκB (p50–p50) prevents
the transcription of proinﬂammatory genes and confers
the anti-inﬂammatory status to M2 macrophages13.
The plasticity of TAMs and their ability to be repro-
grammed, especially from M2 to M1 phenotype, make
them an attractive target for anticancer therapies. Con-
ventional radiotherapy (X-rays or γ-rays) initiated the
polarization of differentiated but unpolarized (M0) mac-
rophages towards M1 when exposed to moderate doses
(1–10 Gy) (for a review, see ref. 14). In addition, the
combination of CD8+ T-cell transfer and γ-ray used at
moderate doses (2 Gy) re-educated TAMs towards an M1
phenotype in a pancreatic tumor mice model10. Other
studies also reported TAM reprogramming after low dose
of whole-body irradiation15, 16. However, no study has
established the reprogramming of M2 into M1 macro-
phages with local conventional RT only. This suggests
that RT alone is not sufﬁcient to reverse macrophage
polarization.
Over the last decades, efforts were aimed to improve the
delivery of conventional RT using image guidance.
Despite these improvements, side effects associated to this
treatment have remained severe. To spare surrounding
healthy tissues, protontherapy presents an increasing
interest, thanks to the charged nature of the particles and
its depth dose proﬁle. In more details, the one-shot energy
release at the end of the charged particle track allows the
improvement of dose conformation. This is added to the
fact that the track of charged particles can be easily
deviated by a magnetic ﬁeld to precisely target the tumor.
As for X-ray irradiation, the deposited energy by charged
particle beam promotes the ionization of DNA through
reactive oxide species (ROS) production. In addition to
these indirect DNA damage, charged particles also
directly interact with DNA, resulting in more complex
DNA damage17. Our work demonstrated the ability of
protontherapy to induce macrophage reprogramming. By
using THP-1-derived M0, M1 and M2 macrophages, we
evidenced that proton irradiation, but not X-ray irradia-
tion, induced a partial switch from M2 to M1 macro-
phages. This macrophage reprogramming is orchestrated,
at least in part, by an NFκB activation.
Results
To address these goals, THP-1 cells were differentiated
(M0) and polarized (M1 or M2) in irradiation chambers
(Fig. 1). These special devices were placed at the end of
the accelerator-produced proton beam and the effects on
macrophages were then analyzed.
M1 macrophages are more resistant to moderate doses of
proton irradiation than M0 and M2 macrophages
In order to evaluate the cell viability after proton
irradiation, ethidium bromide−acridine orange staining
was performed (Fig. 2a) and the number of dead cells
(orange) and viable cells (green) was counted (Fig. 2b).
The cell viability slightly decreased 8 h (Fig. 2b) after
moderate proton irradiation doses (0–10 Gy), as indi-
cated by a survival of 82% for M0 macrophages, 82% for
M1 macrophages, and 78% for M2 macrophages when
irradiated with a dose of 10 Gy. Proton irradiation at 10
Gy further lowered the viability of M0 and M2 macro-
phages respectively to 42 and 50% after 16 h (Fig. 2b).
Surprisingly, the viability of M1 macrophages was only
slightly affected (92%) 16 h after proton irradiation at
doses as high as 10 Gy. These results suggest an early
radioresistance of the M1 phenotype to moderate pro-
ton irradiation doses, compared to the two other
phenotypes.
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M1 radioresistance correlates with more intense γH2AX
and 53BP1 labeling
In order to further examine the inﬂuence of proton
irradiation on macrophages, phosphorylated H2AX (Ser
139) (γH2AX), a sensitive marker for DNA double-strand
breaks (DSBs), was evaluated by immunoﬂuorescence
labeling (Fig. 3a). Quantiﬁcations of γH2AX labeling
(Fig. 3b) 15 min after irradiation indicated a similar proﬁle
for the three macrophage phenotypes when irradiated at
different doses (3, 5, and 10 Gy). However, the
Fig. 1 Schematic outline of the irradiation procedure for macrophages. THP-1 monocytes were differentiated into macrophages (M0) with 150
nM PMA in cloning cylinder, placed at the center of the irradiation chamber. Macrophages were polarized in M1 phenotype with 10 pg/ml LPS and
20 ng/ml IFN-γ during 24 h incubation or were polarized in M2 phenotype with 20 ng/ml IL-4 and IL-13 during 48 h incubation. THP-1 monocytes
were differentiated on the appropriate day, in order to obtain the three phenotypes on day 4. Following the experiment that was performed, the
biological material was collected 8, 12, 16, or 24 h after proton or X-ray irradiation
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Fig. 2 Early radioresistance of M1 macrophages after moderate doses of proton irradiation. M0, M1, and M2 macrophages were irradiated
with different doses of protons. Viability was assessed by ethidium bromide−acridin orange at different times postirradiation. a Representative
ethidium bromide−acridine orange staining images of M1 and M2 macrophages 16 h after proton irradiation (0 Gy and 10 Gy). Lived cells appeared
in green while dead cells are stained in orange. b Quantiﬁcation of viability (%) in M0, M1, and M2 macrophages, 8 or 16 h after proton irradiation.
N= 3 for each dose (mean ± SD). One-way ANOVA analyses followed by Dunnett’s multiple comparisons post-tests were performed on data;
*p ≤ 0.05; **p < 0.01; ***p < 0.001
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quantiﬁcations of γH2AX labeling (Fig. 3c) over the time
post irradiation (0–360min) indicated a similar proﬁle for
M0 and M2 macrophages while M1 phenotype exhibited
a higher level of phosphorylated H2AX. In more details,
γH2AX labeling increased 5min after proton irradiation
(3 Gy) in M0 and M2 phenotypes and was mostly
decreased 2 h after irradiation. In contrast, the γH2AX
labeling was increased and plateaued as long as 6 h after
irradiation in M1 macrophages, indicating an increasing
and prolonged detection of DSBs in this phenotype. In
order to conﬁrm these data, 53BP1 intensity was also
assessed by immunoﬂuorescence labeling (Fig. 3d). 53BP1
is known for its role in DNA repair machinery. Similarly
to γH2AX labeling, the quantiﬁcation of 53BP1 intensity
revealed a sustained labeling over the time in M1 mac-
rophages, while 53BP1 intensity was decreased 1 h after
proton irradiation in M0 and M2 macrophages (Fig. 3e).
As chromatin conformation could inﬂuence the detection
and the repair of DSBs, we evaluated the heterochromatin
content by MNAse I assay in the three different pheno-
types. The radioresistance of M1 macrophages was not
linked to a higher level of DNA condensation before
irradiation since there was no difference in the hetero-
chromatin content in the three phenotypes (Fig. S1). In
addition to sustained γH2AX, the analysis of ROS content
by ﬂow cytometry revealed that M1 macrophages better
managed H2O2 treatment (Fig. S2). Taken together, these
results indicated that the radioresistance of M1 macro-
phages to proton irradiation could be related to higher
DSB detection and/or to better efﬁciency of DNA repair
machinery in this phenotype, and also correlates with a
better elimination of ROS.
Proton irradiation induces macrophage reprogramming
Proton irradiation of M0, M1, and M2 macrophages with
moderate doses promotes the reprogramming of M0 and
M2 macrophages towards an M1 phenotype (Fig. 4).
mRNA levels of several M1 markers (IL-6 and IL-8)
increased signiﬁcantly in M0 macrophages (Fig. 4a, left
panel) exposed to 10 Gy. At the same time, we observed a
signiﬁcant reduction of the mRNA expression of EGF, a
speciﬁc marker of M2 phenotype. Consistent with these
results, the secretion of TNFα was also signiﬁcantly higher
(Fig. 4b, left panel) in this macrophage phenotype after 5 Gy
of proton irradiation. Taken together, these results indi-
cated a polarization of M0 macrophages towards a M1
phenotype after moderate doses of proton irradiation. The
irradiation of M1 macrophages (Fig. 4a, middle panel) did
not exhibit any change in mRNA expression for M1 (TNFα,
IL-6 and IL-8) and M2 (CCL22, IL-10 and EGF) markers.
The secretion of IL-6 and TNFα was then quantiﬁed after
moderate doses of irradiation (Fig. 4b, middle panel). The
results revealed a strengthening of the M1 phenotype in
M1 macrophages. The proton irradiation of M2 macro-
phages (Fig. 4a, right panel) led to a signiﬁcant decrease in
EGF mRNA expression at 5 and 10Gy while the expression
of other M2 markers remained unchanged. The mRNA
level of M1 markers was not affected by proton irradiation.
However, the irradiation of M2 macrophages generated a
signiﬁcant increase in TNFα secretion (Fig. 4b, right panel).
As a whole, proton irradiation (5 and 10Gy) initiated the
polarization of M2 macrophages towards the M1 pheno-
type, thus generating an intermediate phenotype. Similarly
to other studies, X-ray irradiation did not succeed to induce
a reprogramming of M2 macrophages towards an M1
phenotype in our model (Fig. S3). The mRNA expression of
M1 and M2 markers was not affected by X-ray irradiation
in M0 and M2 macrophages, while the mRNA level of EGF
was reduced in irradiated M1 macrophages. In addition, the
secretion of TNFα was elevated in irradiated M1 macro-
phages, consistent with a strengthening of the M1 pheno-
type in M1 macrophages.
Proton irradiation orchestrates NFκB p65 nuclear
translocation in macrophages
To investigate the mechanism underlying macrophage
reprogramming after moderate doses of proton irradia-
tion, the nuclear translocation of NFκB p65 subunit was
(see ﬁgure on previous page)
Fig. 3 M1 resistance to proton irradiation correlates with a higher γH2AX and 53BP1 labeling. M0, M1, and M2 macrophages were irradiated
with different doses of protons. The evaluation of DNA damage following proton irradiation was performed by phosphorylated H2AX (γH2AX) or
53BP1 labeling. a Representative immunoﬂuorescence labeling of γH2AX for M0, M1, and M2 macrophages 15 min after proton irradiation. γH2AX
labeling appears in green and nuclei are stained in blue (To-pro). b Quantiﬁcation of the mean γH2AX intensity per nucleus 15 min after proton
irradiation. Results are expressed in mean pixel intensity value and are normalized to the nonirradiated condition (fold change). Quantiﬁcations were
performed on minimum ﬁve images per condition; representative experiment (N= 3, mean ± SD). c Mean γH2AX intensity after proton irradiation (3
Gy), several times postirradiation. Each point corresponds to the mean γH2AX intensity at time t (Tt) normalized to time 0 (T0). Quantiﬁcations were
performed on minimum ten images per condition; representative experiment, N= 3 (mean ± SD). One-way ANOVA analyses were performed on
data, followed by Dunnett’s post-tests; *p ≤ 0.05; **p < 0.01; ***p < 0.001. d Representative immunoﬂuorescence labeling of 53BP1 for M0, M1, and M2
macrophages 15 min after proton irradiation. 53BP1 labeling appears in green and nuclei are stained in blue (To-pro). e Quantiﬁcation of the 53BP1
intensity per nucleus after proton irradiation (3 Gy), several times postirradiation. Each point corresponds to the mean 53BP1 intensity at time t (Tt),
normalized to time 0 (T0). Quantiﬁcations were performed on ﬁve images per condition; N= 1 (mean ± SD). One-way ANOVA analyses were
performed on data, followed by Dunnett’s post-tests; *p ≤ 0.05; **p < 0.01; ***p < 0.001
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evaluated after the irradiation. This translocation was
analyzed in M0, M1, and M2 macrophages at different
times postirradiation (0, 5, 15, 30, 60, 90, 120, and
360min) (data not shown) and was observed in the three
phenotypes 2 h after the irradiation (Fig. 5a). The quan-
tiﬁcation of highly positive cells for NFκB p65 suggested a
nuclear translocation of NFκB p65 in M0, M1, and M2
macrophages after proton irradiation (5 and 10 Gy)
(Fig. 5b).
NFκB inhibition reverts macrophage reprogramming
induced by proton irradiation
To study the role of NFκB in proton beam-mediated
macrophage reprogramming, we assessed the mRNA level
of M1 and M2 markers in M0 and M2 macrophages 12 h
after Bay 11-7082 (IKK inhibitor) treatment combined
with proton irradiation (Fig. 6). Based on preliminary
results, we chose to treat macrophages during 12 h with
5 µM of Bay 11-7082 inhibitor. Indeed, for longer
Fig. 4 Proton irradiation induces macrophage reprogramming. M0, M1, and M2 macrophages were irradiated with different doses of protons (0,
5, and 10 Gy). a 24 h after proton irradiation, mRNA levels of M1 (TNFα, IL-6, IL-8) and M2 (CCL22, IL-10, EGF) markers were assessed by RT-qPCR
(N= 3, mean ± SD). One-way ANOVA analyses followed by Dunnett’s multiple comparison tests were performed to evaluate the signiﬁcance
(*p ≤ 0.05; **p < 0.01; ***p < 0.001). b 24 h after proton irradiation, TNFα, IL-8, and IL-6 secretion was evaluated by ELISA. Results are expressed in
pg/ng of proteins and are normalized to the nonirradiated condition (fold change) for each macrophage phenotype; ND was used for not detected
(N= 3, mean ± SD). One-way ANOVA analyses followed by Kruskal−Wallis multiple comparison tests were performed on data (*p ≤ 0.05; **p < 0.01;
***p < 0.001)
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incubation time and for higher concentrations, we
observed a cell death higher than 20% (data not shown).
In accordance with the results from Fig. 4a, the proton
irradiation (10Gy) of M0 macrophages displayed a non-
signiﬁcant increase in M1 marker mRNA levels (TNFα, IL-
6, and IL-8) 12 h after irradiation while the mRNA
expression of M2 markers was not inﬂuenced by the
irradiation (Fig. 6a). The combination of the IKK inhibitor
with the proton irradiation completely inhibited the
programming of M0 into M1 phenotype and induced a
nonsigniﬁcant increase in M2 marker expression (CCL22,
IL-10, and EGF). Although Bay 11-8072 treatment alone
drove the expression of IL-10 and EGF, the combination
of the inhibitor with proton irradiation induced a much
higher expression of these genes. The same experiment
has been performed for M2 macrophages (Fig. 6b). As it
was aforementioned, the irradiation of M2 macrophages
had no effect on the M1 marker mRNA levels after 24 h
(Fig. 4a) and we detected no change in the TNFα and IL-8
mRNA expression after 12 h (Fig. 6b). However, a
decrease in IL-6 expression was noticed in the same
condition. When proton irradiation was combined to
NFκB inhibition, diverse effects were observed on the
expression of M1 markers. No effect was observed on
TNFα expression, while the expression of IL-8 surpris-
ingly increased when proton irradiation was combined to
Bay 11-7082 treatment. As the activation of NFκB reg-
ulates the expression of IL-8, it is surprising to observe an
elevation of the IL-8 mRNA level in M2 macrophages
irradiated in the presence of Bay 11-7082. However, the
transcription of IL-8 is also regulated by other transcrip-
tion factors, such as the activator protein 1 (AP-1), that
could be also activated when NFκB is inhibited in proton-
irradiated M2 macrophages18. On the other hand, IL-6
expression was strongly decreased by the IKK inhibitor: its
expression decreased by four times with Bay 11-7082
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Fig. 5 Proton irradiation induces nuclear translocation of p65 (NFκB). M0, M1, and M2 macrophages were irradiated by different doses of
protons. 2 h after the irradiation, the nuclear translocation of p65 was evaluated by NFκB p65 immunoﬂuorescence labeling. NFκB p65 is stained in
green and nucleus appears in blue. a Nuclear translocation of NFκB p65 is indicated (arrow) on representative immunoﬂuorescence labeling images
for M0, M1, and M2 macrophages after irradiation. b Quantiﬁcation of the mean NFκB p65 intensity per nucleus 2 h after proton irradiation. Results
are expressed in percentage of cells with nuclear NFκB p65. Quantiﬁcations were performed on minimum ﬁve images per condition (N= 3, mean ±
SD). An unpaired t test was performed on data (*p ≤ 0.05; **p < 0.01; ***p < 0.001)
Genard et al. Cell Death and Disease  (2018) 9:728 Page 7 of 13
Ofﬁcial journal of the Cell Death Differentiation Association
Fig. 6 NFκB inhibition reverts proton irradiation-induced macrophage reprogramming. M0 and M2 macrophages were irradiated (IR) with
protons (10 Gy) with or without NFκB inhibitor (Bay 11-7082—5 μM). The inhibitor was added 1 h before irradiation for the following 12 h.
Macrophage polarization was evaluated by RT-qPCR 12 h after proton irradiation by the analysis of M1 (TNFα, IL-6, IL-8) and M2 (CCL22, IL-10, EGF)
marker mRNA level in (a) M0 macrophages (N= 3, mean ± SD) and b M2 macrophages (N= 4, mean ± SD). Two-way ANOVA analyses followed by
Tukey’s multiple comparison tests were performed on data; *p ≤ 0.05; **p < 0.01; ***p < 0.001
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alone and by ﬁve times with the combination. For M2
markers, proton irradiation alone did not alter
the expression of these markers after 24 h (Fig. 4a). In the
same line, 10 Gy of irradiation did not change the
expression of M2 markers after 12 h (Fig. 6b). However,
the combination of NFκB inhibitor to proton irradiation
induced a higher expression of M2 markers. The elevation
of M2 marker expression was stronger in M2 macro-
phages exposed to the combined treatment than for
macrophages treated with the inhibitor alone. In conclu-
sion, the NFκB inhibitor combined to proton irradiation
completely prevented the programming of M0 macro-
phages towards an M1 phenotype. On the contrary, it
promoted the programming of M0 macrophages towards
an M2 phenotype. In addition, M2 macrophages reinforce
their M2 phenotype when exposed to proton irradiation
in combination with Bay 11-7082.
Discussion
As M2-like TAMs play an important role in tumor
promotion and treatment failure, the reprogramming of
these cells has been shown to be an efﬁcient way to
promote tumor regression. It is already known that
macrophages are more radioresistant compared to other
cell types19. Indeed, the fusion of macrophages with breast
cancer cell line (MCF7) resulted in hybrids developing the
abilities to resist high radiation doses and to repair DNA
damage faster than the parental MCF7 cells20. In the
present study, we demonstrated the radioresistance of M1
macrophages compared to M0 and M2 phenotypes. Sev-
eral evidences highlighted the radioresistance of M1
macrophages in the literature. For example, BALB/c mice
naturally exhibiting a TH1/M1 (TH1 lymphocytes and M1
macrophages) response were more radioresistant than
C57BL/6 mice naturally exhibiting a TH2/M2 response
16.
TNFα play key roles in macrophage radioresistance since
an intact TNFα signaling is needed for radioresistance.
Indeed, the deletion of tumor necrosis factor receptor 1 or
2 (TFNR1 or TNFR2) in mice rendered macrophages
radiosensitive21. In contrast to our observations, a recent
in vitro study indicated that unpolarized (M0) and M1
macrophages were more sensitive to X-ray irradiation
than M2 macrophages. The divergent results could be
explained by the use of higher LPS concentration (100 ng/ml
instead of 10 pg/ml in the present study) for the polar-
ization process before the irradiation22.
The resistance of M1 macrophages to proton irradiation
correlated with a higher level of phosphorylated H2AX,
possibly indicating either more DSBs, or a higher activity of
DNA damage repair. Another explanation could rely on the
ability of macrophages to detoxify irradiation-induced
radicals formed upon H2O radiolysis. It is well established
that the radioresistance of macrophages is conferred by a
high production of anti-oxidative molecules, such as
manganese superoxide dismutase (MnSOD). Higher
MnSOD expression is associated to a resistance against
damaging effects from ROS and reactive nitrogen species23.
Indeed, the scavenging of ROS by N-acetyl-L-tryptophan
glucopyranoside (NATG) in J774A.1 macrophages provided
a protection against radiation-dependent apoptosis24. Fur-
thermore, another in vitro study revealed that mouse peri-
toneal macrophages polarized towards the M1 phenotype
with methionine displayed increased SOD activity and
decreased ROS production25. In our experiments, the ana-
lysis of ROS management revealed a more efﬁcient elim-
ination of ROS in M1 macrophages when challenged with
H2O2 compared to M0 and M2 macrophages (Fig. S2). In
conclusion, the radioresistance of M1 macrophages to
proton irradiation is related to a higher DNA damage
detection. Several causes like a larger antioxidant pool, a
more active DNA repair machinery and the differential
promoter methylation of genes involved in DNA repair
should be taken in considerations for future studies.
Macrophage re-education represents a promising
approach to reverse the fate of tumor and generates
tumor regression. To our knowledge, this is the ﬁrst
observation of in vitro macrophage reprogramming with
particle therapy. Previous studies with conventional
radiotherapy (X-rays or γ-rays) revealed an efﬁcient pro-
gramming of unpolarized macrophages (M0) towards the
M1 phenotype but not M2 reprogramming towards M1-
like phenotype (for a review, see ref. 14). For example, the
irradiation of monocyte-derived macrophages with frac-
tionated doses (2 Gy 5 × /week) induced the polarization
towards M1-like macrophages as evidenced by a higher
expression of proinﬂammatory genes and a down-
regulation of anti-inﬂammatory genes26. Another study
also revealed the programming of unpolarized macro-
phages towards a proinﬂammatory proﬁle after moderate
dose of γ-irradiation (2 or 4Gy)27. In the last study, the
authors also reported an increased expression of IL-6, IL-8,
and TNFα in γ-irradiated (4 Gy) human monocyte-
derived macrophages. While the use of X-ray irradiation
induced an M1 polarization of unpolarized human
monocyte-derived macrophages, Raw 264.7 cells, PMA-
differentiated THP-1 cells and peritoneal macrophages14,
our results indicated that X-ray irradiation failed to pro-
gram PMA-differentiated THP-1 macrophages in our
experimental settings. In our experiments, a resting time
period of 24 h allowed a decrease in NFκB gene cluster
expression, upregulated during PMA-induced differ-
entiation28. This may explain the discrepancy with pre-
viously reported results. The release of TNFα by M0, M1,
and M2 macrophages after proton irradiation conﬁrms
the reprogramming of macrophages to an M1-like phe-
notype. Indeed, TNFα is a potent anti-M2 polarization
factor and strongly correlates with an M1-like pheno-
type29. Inversely, a decrease in mRNA expression of EGF
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was shown for the three phenotypes upon irradiation.
EGF is well known to be involved in both angiogenesis
and cell migration, two roles fulﬁlled by M2
macrophages30.
The active heterodimer NFκB p50–p65 is predominant
for M1 activation, leading to a proinﬂammatory proﬁle
while the induction of the inactive homodimer NFκB
p50–p50 inhibits the expression of proinﬂammatory
genes in M2 macrophages12, 13. Our results demonstrated
the implication of NFκB p65 subunit in macrophage
reprogramming after moderate doses of proton irradia-
tion. In addition, the combination of proton irradiation to
an IKK complex inhibitor (Bay 11-7082) completely
aborted the re-education towards a M1 phenotype in M0
and M2 macrophages. In general, NFκB is activated in
irradiated cancer cells when doses are comprised in the
range of 7−10 Gy31–33. Similarly to our study, the X-ray
irradiation of monocyte-derived macrophages also
induced the upregulation of total and phosphorylated p65,
from 1 to 6 h after irradiation at 2 Gy and 10 Gy. This was
correlated to the reduced expression of anti-inﬂammatory
genes26. Furthermore, the whole-body irradiation of RT5
insulinoma bearing mice increased NFκB p65 phosphor-
ylation in tumors, partially explaining the TAM repro-
gramming after γ-irradiation15. Proton irradiation is also
more likely to induce more severe DNA damage and
higher ROS production compared to photons34. These
damages activate the DNA repair system, including ATM
(ataxia-telangiectasia mutated) kinase, notably responsible
for the translocation of NFκB p65 into the nucleus35.
Hence, ROS production and double DNA strand breaks
are strongly linked to NFκB p65 activation14, 36. In addi-
tion, other studies have demonstrated the activation of
NFκB p65 in cancer cells after high LET charged
particle irradiation. Indeed, heavy ions with a LET of
100–300 keV/μm showed up to nine times higher
potential to activate the NFκB pathway compared to
X-rays37 while carbon ions with a LET under 73 keV/μm
induced an NFκB p65 activation twice as high as the one
induced by conventional radiotherapy38. For future stu-
dies, the use of high LET radiation should be considered,
as it can potentiate the activation of NFκB in macrophages
and induce apoptosis in cancer cells. However, further
investigations are needed to clarify if charged particle
therapy may be used for all cancer types. Indeed, con-
stitutive activation of NFκB is associated to tumor growth
for several human cancer cells such as breast cancer,
colon cancer, prostate cancer, and lymphoid cancer. In
cancer cells, NFκB plays key roles in cell survival, notably
by regulating the expression of genes involved in cell
survival and cell cycle38. For conventional radiotherapy,
the use of NFκB inhibitors increased the radiosensitivity
of many cancer cells39. However, no study has been per-
formed yet to assess the balance between NFκB-mediated
survival and apoptosis in high LET radiation context.
Also, the activation of the immune system by particle
therapy could overcome the activation of NFκB in cancer
cells. These questions reveal a need for further investi-
gations regarding the use of charged particle therapy in
cancer.
Our study provides direct evidences that there could be
a selection of M1 macrophages in tumors with proton
irradiation, since this phenotype is more radioresistant.
Furthermore, we showed that 10 Gy of proton irradiation
is able to program M0 macrophages towards M1 pheno-
type, to enhance the M1 phenotype in M1 macrophages
and to initiate an M1 phenotype in M2 macrophages. This
re-education is due, at least in part, to NFκB p65 activa-
tion. Therefore, our data open new perspectives for
macrophage clinical targeting with charged particle ther-
apy. In the future, these results need to be conﬁrmed by
in vivo experiments, as other cell types are present in the
tumor microenvironment and could inﬂuence the
response to proton irradiation. It has to be noted that
macrophage reprogramming after proton irradiation may
not be exclusively associated to NFκB activation. Indeed,
the interaction between several pathways (NFκB, MAPK,
and IRF/STAT pathways) may be involved in this process
and needs to be further investigated. Moreover, metabo-
lism reprogramming has been demonstrated to inﬂuence
macrophage polarization40, 41 and should be taken into
account in the further studies.
Materials and methods
Differentiation of monocytes to macrophages and
macrophage polarization
Human monocytic cell line (THP-1–ATCC TIB-202)
were grown in Roswell Park Memorial Institute (RPMI
1640, Gibco #21875034) culture medium containing 10%
of heat inactivated fetal bovine serum (Gibco) and
supplemented with 10 mM Hepes (Gibco, #15630-056),
2 mM pyruvate (Gibco, #11360-039), 2.5 g/L D-glucose
(Merck) and 50 pM β-mercaptoethanol (Gibco, #31350-
010). As the proton accelerator used in this study pro-
duces a horizontal beam, cells were plated in suitable
irradiation chambers, composed of two stainless steel
rings with the central holes covered by 3 μm Mylar foils
(Goodfellow). THP-1 monocytes were seeded at the
center of irradiation chambers, on the Mylar foil, and
differentiated into macrophages with 150 nM phorbol 12-
myristate 13-acetate (PMA, Sigma P8139). For this step, a
cloning cylinder (6.4 mm diameter size, Sigma C3983-
50EA) was placed at the center of the chamber and ﬁlled
with Cell Tak (VWR #354240) for coating. Differentiated
THP-1 cells tend to form clusters when seeded on Mylar
foil and Cell tak allowed a homogenous monolayer. The
cloning cylinders were rinsed with milli Q water and were
ﬁlled with 190 μl of medium containing 50,000 THP-1
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monocytes, penicillin streptomycin 10,000 U/ml (Fisher,
#15140122) and PMA for 24 h incubation. The differ-
entiation medium was replaced with RPMI medium for a
further 24 h incubation. Macrophages were polarized in
M1 phenotype with 10 pg/ml lipopolysaccharides (LPS,
Sigma; #8630) and 20 ng/ml interferon γ (IFN-γ, R&D
Systems, #285-IF) during 24 h incubation or were polar-
ized in M2 phenotype with 20 ng/ml interleukin 4 (IL-4,
R&D Systems, #204-IL) and 20 ng/ml interleukin 13 (IL-
13, R&D Systems, #213-ILB) during 48 h incubation as
described in ref. 42. The gene expression of M1 (IL-1β,
TNFα, CXCL10, and IL-6) and M2 (CCL18, CCL22,
CD206, and IL-10) markers were analyzed to verify the
macrophage phenotype of M0, M1, and M2 macrophages
in the irradiation chambers (Fig. 4S).
Proton irradiation
Four days before irradiation, THP-1 monocytes were
differentiated in the irradiation chambers to generate M2
macrophages. To obtain M1 or M0 macrophages, cells
were seeded 3 or 2 days respectively before irradiation.
Just before proton irradiation, culture medium was
changed by CO2 independent medium (Gibco #18045054)
supplemented with 2 mM L-glutamine and 3.75 g/L of
D-glucose. The irradiation chambers were placed at the
end of a 2MV Tandem accelerator (High Voltage Engi-
neering Europa) available at the University of Namur. The
experimental set-up and irradiation procedure are
described elsewhere43, 44. Brieﬂy, an H+ homogenous
1 cm2 broad beam went through a 1-μm-thick Si3N4 exit
foil. The chambers were placed vertically at 3 mm from
the exit window of the accelerator. The linear energy
transfer (LET) of protons was set to 25 keV/μm and the
dose rate ﬁxed to 2 Gy/min. After irradiation, the cham-
bers were replaced in the CO2 incubator until the
experiments were performed.
One of the constraints of this set-up is the need to have
cells that adhere to the Mylar foil that constitutes the
bottom of the irradiation chamber. We cannot use usual
plastic ﬂaks/plates since the proton beam generated by
our particle accelerator does not have enough energy to
go through this material. Most cell lines do not adhere to
this material and/or form clusters that do not allow a
homogeneous irradiation of all cells. Hence, this work has
been performed using THP1-derived macrophages only.
Determination of cell viability
Because of the Cell Tak, the cells could not be detached
from the Mylar foil. Ethidium bromide (1 mg/ml Sigma
E8751)−acridin orange (0.3 mg/ml, Sigma A6014)
(EBAO) was used at 1:100 dilution in PBS to analyze
viability. The cells were stained with EBAO for 5 min, 8 h,
or 16 h after irradiation. Cells were then rinsed with PBS
and were observed with Olympus stream microscope
beyond UV light. Live cells are stained in green while dead
cells are stained in orange. Quantiﬁcations were per-
formed with Aphelion Lab® software on approximately
1000 cells.
Immunoﬂuorescence labeling
Cells were ﬁxed for 10 min with paraformaldehyde 4%
in PBS, and then permeabilized with triton 0.1% for 5 min.
The cells were rinsed three times with PBS–BSA 2%
(bovine serum albumin) and incubated overnight at 4 °C
with primary antibody in the irradiation chambers. Pri-
mary antibodies were 1:800 (γH2AX, BioKe 2577), 1:400
(NFκB p65, Cell Signaling D14E12) or 1:1500 (53BP1,
Novus NB100-304) diluted in PBS–BSA 2%. Cells were
rinsed three times with PBS–BSA 2% and then incubated
for 1 h with secondary antibody 1:1000 diluted (Alexa
Fluor 488-conjugated anti-rabbit IgG antibody; Molecular
Probes, #A11034) at room temperature. After washing the
cells three times with PBS, nuclei were stained with
TOPRO-3 (1:80 diluted in RNase solution). Cells were
then washed three times with PBS and the Mylar foil was
cut around the cell drop and was deposited on a micro-
scope slide, cells on top. A coverslip was mounted using
Mowiol (Sigma) above the cells and the cells were
observed with a confocal microscope (SP5, Leica). A
constant photomultiplier gain value and a constant laser
power were used to take the pictures. Quantiﬁcations for
γH2AX intensity or 53BP1 foci were performed using
Aphelion Lab® software on approximately 1000 cells. For
γH2AX, the quantiﬁcation was performed as followed:
mean of (Number of green pixels × intensity of each
pixel) / nucleus. Usually, the quantiﬁcation of γH2AX
labeling is performed by counting γH2AX foci. However,
as high doses were used in this study, large numbers of
clustered foci were observed and it was impossible to
discriminate foci at these doses. Therefore, we choose to
quantify the mean intensity of γH2AX per nucleus.
Apoptotic cells were not taken into account for the
quantiﬁcation. Quantiﬁcation for 53BP1 foci was per-
formed similarly. Quantiﬁcation for NFκB p65 was per-
formed as followed: number of cells with higher pixel
numbers than mean+ 2 standard deviations, representa-
tive of cells with high translocation of NFκB p65.
Relative quantiﬁcation of mRNA levels
Total RNA was extracted from cells in irradiation
chambers with RNeasy micro kit and DNAse protocol
(QIAGEN # 74004). Reverse transcription was performed
on 1 μg using Transcriptor ﬁrst strand cDNA synthesis kit
(Roche #4309155). The quantitative Real Time PCR was
performed using Viia 7 (Thermo Fisher Scientiﬁc) with
SYBRGreen PCR Master Mix (Applied Biosystems,
#4309155) and primers (IDT, 300 nM). 40S ribosomal
protein S9 (RPS9) was selected as the housekeeping gene
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for normalization, based on its constant expression within
all samples. The primers used for RT-qPCR are sum-
marized in supplementary information (table S1).
Cytokine quantiﬁcation
Secreted cytokine (IL-6, CXCL-8/IL-8, and TNFα)
analysis was assessed using ELISA kit, according to the
manufacturer’s recommendations (Quantikine, R&D
Systems D6050, D8000C and DTA00C). Culture media
were diluted in CO2 independent medium 5 and 50 times
for TNFα and IL-8, respectively, while the culture med-
ium was not diluted for IL-6. For all samples, concentra-
tions were normalized by total protein (μg proteins/ml)
determined by Folin method.
IKK inhibition
Bay 11-7082 inhibitor (3-((4-methylphenyl)sulfonyl)-
(2E)-propenenitrile; Selleckchem S2913) selectively and
irreversibly inhibits the phosphorylation of IκB-α and
then prevents the NFκB activation. This inhibitor was
added at 5 μM in CO2 independent medium 1 h before
irradiation and the cells were incubated for 12 h after irra-
diation in the presence of the inhibitor. TNFα (20 ng/ml,
R&D Systems #210-TA-020) was used as a positive con-
trol to verify the nuclear translocation of NFκB p65. In
order to validate the inhibition of p65 nuclear transloca-
tion in our model, cells were incubated with TNFα and
Bay 11-7082 (Fig. 5S).
Statistical analysis
Statistical analyses were performed using Graph Pad
Prism software. Data are reported as mean ± 1SD of N
independent experiments. A p value of <0.05 was con-
sidered as signiﬁcant.
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